| Wissenschaftl. Titel | A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Global Study of Rilvegostomig in Combination With Chemotherapy as Adjuvant Treatment After Resection of Biliary Tract Cancer With Curative Intent (ARTEMIDE-Biliary01) |
| Erkrankung | |
| weitere Prüfzentren | |
| Kurzprotokoll | Kurzprotokoll |
erstellt 19.12.2024 Admin07
geändert 19.12.2024 Admin07